Epratuzumab (Anti-Siglec-2 / CD22)
A3056
Product group Antibodies
Overview
- SupplierSelleck Chemicals
- Product NameEpratuzumab (Anti-Siglec-2 / CD22)
- Delivery Days Customer9
- CertificationResearch Use Only
- Estimated Purity...
- Scientific DescriptionEpratuzumab (Anti-Siglec-2 / CD22) is a IgG1 monoclonal antibody targeting CD22. It has been used to research non-Hodgkins lymphomas (NHL) and certain autoimmune diseases. MW: 155.4 KD.
- Storage Instruction-20°C
- UNSPSC12352203